These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26467148)

  • 1. Optimal designs for a multiresponse Emax model and efficient parameter estimation.
    Magnusdottir BT
    Biom J; 2016 May; 58(3):518-34. PubMed ID: 26467148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous estimation of parameters in the bivariate Emax model.
    Magnusdottir BT; Nyquist H
    Stat Med; 2015 Dec; 34(28):3714-23. PubMed ID: 26190048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the combination of c- and D-optimal designs: General approaches and applications in dose-response studies.
    Holland-Letz T
    Biometrics; 2017 Mar; 73(1):206-213. PubMed ID: 27218478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothesis testing and Bayesian estimation using a sigmoid Emax model applied to sparse dose-response designs.
    Thomas N
    J Biopharm Stat; 2006; 16(5):657-77. PubMed ID: 17037264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of maximin efficient designs in dose-finding studies.
    Fackle-Fornius E; Miller F; Nyquist H
    Pharm Stat; 2015; 14(1):63-73. PubMed ID: 25405333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the efficiency of two-stage response-adaptive designs.
    Dette H; Bornkamp B; Bretz F
    Stat Med; 2013 May; 32(10):1646-60. PubMed ID: 22865374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporating correlation in interindividual variability for the optimal design of multiresponse pharmacokinetic experiments.
    Ogungbenro K; Graham G; Gueorguieva I; Aarons L
    J Biopharm Stat; 2008; 18(2):342-58. PubMed ID: 18327725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-optimal designs for parameter estimation for indirect pharmacodynamic response models.
    Khinkis LA; Krzyzanski W; Jusko WJ; Greco WR
    J Pharmacokinet Pharmacodyn; 2009 Dec; 36(6):523-39. PubMed ID: 19904585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptive Optimal Designs for Dose-Finding Studies with Time-to-Event Outcomes.
    Ryeznik Y; Sverdlov O; Hooker AC
    AAPS J; 2017 Dec; 20(1):24. PubMed ID: 29285730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive designs for dose-finding studies based on sigmoid Emax model.
    Dragalin V; Hsuan F; Padmanabhan SK
    J Biopharm Stat; 2007; 17(6):1051-70. PubMed ID: 18027216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient design for estimation of median lethal dose and quantal dose-response curves.
    Kalish LA
    Biometrics; 1990 Sep; 46(3):737-48. PubMed ID: 2242412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of experiments for the precise estimation of dose-response parameters: the Hill equation.
    Bezeau M; Endrenyi L
    J Theor Biol; 1986 Dec; 123(4):415-30. PubMed ID: 3657186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Start-up designs for response-adaptive randomization procedures with sequential estimation.
    Haines LM; Sadiq H
    Stat Med; 2015 Sep; 34(21):2958-70. PubMed ID: 25944171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient algorithms for optimal designs with correlated observations in pharmacokinetics and dose-finding studies.
    Holland-Letz T; Dette H; Renard D
    Biometrics; 2012 Mar; 68(1):138-45. PubMed ID: 21838804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian optimal adaptive designs for delayed-response dose-finding studies.
    Li W; Fu H
    J Biopharm Stat; 2011 Sep; 21(5):888-901. PubMed ID: 21830921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential allocation trial design in anesthesia: an introduction to methods, modeling, and clinical applications.
    Görges M; Zhou G; Brant R; Ansermino JM
    Paediatr Anaesth; 2017 Mar; 27(3):240-247. PubMed ID: 28211193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parameter estimation for sigmoid E
    Choe S; Lee D
    Transl Clin Pharmacol; 2017 Jun; 25(2):74-84. PubMed ID: 32133323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accounting for variability in sample size estimation with applications to nonadherence and estimation of variance and effect size.
    Fay MP; Halloran ME; Follmann DA
    Biometrics; 2007 Jun; 63(2):465-74. PubMed ID: 17688499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design considerations and analysis planning of a phase 2a proof of concept study in rheumatoid arthritis in the presence of possible non-monotonicity.
    Liu F; Walters SJ; Julious SA
    BMC Med Res Methodol; 2017 Oct; 17(1):149. PubMed ID: 28969588
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.